Our Research
Enhanced Vet Sciences (EVS) 3+ Year Pet & Equine clinical trials for palatability, safety & mobility support with feeding guidelines are now complete.
EVS Proprietary Formulations & Products include 5 Years of Clinical Studies at Leading US-Based Universities
Welcome to a world where cutting-edge research meets your beloved pets’ well-being. At Enhanced Vet Sciences, we’re dedicated to bringing you the latest advancements in pet care. Our comprehensive range includes Clinical Studies, Pet Chews, Pet Toppers, and more all designed with one goal in mind: to enhance your furry companion’s quality of life.
Clinical Studies: Dive into the realm of scientific validation. Our Clinical Studies provide you with evidence-backed insights into how CBD can benefit your pet’s health, mobility, joint pain and palatability. We’re committed to transparency, and these studies are the foundation of our commitment to excellence. Enhanced Vet Sciences is the only online store to buy 100% all natural CBD pet products that have proven clinical research & clinical studies for all the pets chews, pet toppers, pet food and equine health toppers.
Many of the EVS proprietary formulations include broad-spectrum hemp. All is Based on our genetics, growing, cultivation and formulation, Additionally, we have been able to remove the THC to a non-detectable status in our products
Our proprietary formulations and clinical studies have debunked common opinion that high THC levels are necessary in creating effective hemp or CBD related products.
We’re committed to tracking, tracing and transparency, and these studies are the foundation of our commitment to excellence.
Links to published
Research Articles
Click Below for articles
-
Feeding treats containing cannabidiol (CBD) did not alter canine immune response to immunization with a novel antigen
-
Feeding Cannabidiol (CBD)-Containing Treats Did Not Affect Canine Daily Voluntary Activity
-
The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test
-
Alteration of the Canine Metabolome After a 3-Week Supplementation of Cannabidiol (CBD) Containing Treats: An Exploratory Study of Healthy Animals (FINAL)
-
Canine Carboxyl- and Hydroxyl-Containing Metabolites Altered after a Three-Week Supplementation of Cannabidiol (CBD)-Containing Treats in an Exploratory Study (FINAL)
-
Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses
-
Alteration of the Canine Metabolome After a 3-Week Supplementation of Cannabidiol (CBD) Containing Treats: An Exploratory Study of Healthy Animals (FINAL)
-
Pharmacokinetics of cannabidiol in a randomized crossover trial in senior horses
-
The effects of cannabidiol on immune function and health parameters in senior horses (FINAL)
Our Canine Research
Mobility Support
Our 3+ year studies at leading US universities concluded that our formulations support mobility.
Palatability
In both university studies and national sample tastings , dogs love our savory chews.
Safety Studies
Our 3+ year studies showed no side effects, liver toxicity or drug interactions with existing medications when using as per feeding guidelines.
Feeding Guidelines
For dogs, our studies used 2 mg per pound body weight for 3 weeks, and thereafter 1 to 2 mg per pound as required, for optimal results.
Our Equine Research
Our final equine trials were defended in late 2022 and final results published in January 2023. Concluding EVS proprietary full spectrum hemp with non-detectable THC is safe at effective in the reduction of inflammation in horses The studies concluded that 1 mg per 2 pounds body was most effective.
Whether it’s helping older horses feel young and active again or for inflammation prevention, it’s our research first scientific approach delivers full spectrum hemp products unlike any other currently on the market.
Phytocannabinoid Science Driven by What Your Pet Needs Most
Our Path to Success
Overview of Our Clinical Trials
2017
Year 1
Enhanced Pet Sciences established as a clinical and R&D company.
As part of its partnership agreement with leading Universities, in addition to funding, EPS has supplied all hemp-derived formulates used in the clinical trials.
2018
Year 2
The 3-year pet research clinical trials and equine studies at UK Gluck kicked off in early 2018.
Dr. David Harmon is leading the UK Food and Animal Canine research with support from Dr. Kitts-Morgan at LMU Virginia & Tennessee.
Dr. Amanda Adams leads the UK Gluck Equine research.
2019
Year 3
The first phases of safety and dosing standards completed in early 2019.
2020
Year 4
Initial phases of efficacy studies completed in mid 2020. Some delays were experienced due to COVID-19 Pandemic.
2021
Year 5
Final phases of efficacy completed in Q4 2021 demonstrating results around anti-inflammation, anti-itching, insulin regulation, microbiome support, anti-fungal and anti-oxidative functions.
2022
Year 6
Efforts are underway for submission of completed peer reviewed publications and indication claim applications to regulatory bodies such as NASC. These studies include mobility support but not limited to, safety, dosing, and the absence of adverse events.
2023
Year 7
Our final equine trials were defended in late 2022 and final results published in January 2023. Concluding EVS proprietary full spectrum hemp with non-detectable THC is safe and effective in the reduction of inflammation for increased mobility in horses.
The studies concluded that 1 mg per 2 pounds body was most effective.
100% Satisfaction Guarantee. We Stand by Our Science.
We know its hard to trust a product that sounds too good to be true. That’s why were proud to offer our 90 days purchase price back guarantee!* Please contact customer support for more details.
We hold ourselves to the highest standards when it comes to your satisfaction.